Isuzinaxib hydrochlorideProduct ingredient for Isuzinaxib
- Name
- Isuzinaxib hydrochloride
- Drug Entry
- Isuzinaxib
Isuzinaxib is under investigation in clinical trial NCT05758896 (Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI).
- Accession Number
- DBSALT003514
- Structure
Structure for Isuzinaxib hydrochloride (DBSALT003514)
- Synonyms
- 1-(PYRIDIN-2-YL)-3-PHENYL-4-PROPYL-1H-PYRAZOL-5-OL HYDROCHLORIDE / 1H-PYRAZOL-5-OL, 3-PHENYL-4-PROPYL-1-(2-PYRIDINYL)-, HYDROCHLORIDE (1:1) / 3-PHENYL-4-PROPYL-1-(2-PYRIDINYL)-1H-PYRAZOL-5-OL HYDROCHLORIDE / 3-PHENYL-4-PROPYL-1-(PYRIDIN-2-YL)-1H-PYRAZOL-5-OL HYDROCHLORIDE
- External IDs
- APX 115 / APX-115 / APX115 / EWHA 18278 / EWHA-18278 / EWHA18278
- UNII
- Q99G5ZE5U5
- CAS Number
- 1395946-75-4
- Weight
- Average: 315.8
Monoisotopic: 315.1138399 - Chemical Formula
- C17H18ClN3O
- InChI Key
- GMFJXGGAGPCRBM-UHFFFAOYSA-N
- InChI
- InChI=1S/C17H17N3O.ClH/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15;/h3-7,9-12,21H,2,8H2,1H3;1H
- IUPAC Name
- SMILES
- Cl.CCCC1=C(O)N(N=C1C1=CC=CC=C1)C1=CC=CC=N1
- External Links
- ChemSpider
- 78316329
- ChEMBL
- CHEMBL4650358
- Predicted Properties
Property Value Source